المؤلفون: Diener HC; Institute for Medical Informatics, Biometry and Epidemiology, Medical Faculty, University Duisburg-Essen, Essen, Germany., Grosse GM; Institute for Medical Informatics, Biometry and Epidemiology, Medical Faculty, University Duisburg-Essen, Essen, Germany.; Department of Neurology, Hannover Medical School, Hannover, Germany.; Department of Neurology and Stroke Center, University Hospital Basel, Basel, Switzerland., Hüsing A; Institute for Medical Informatics, Biometry and Epidemiology, Medical Faculty, University Duisburg-Essen, Essen, Germany., Stang A; Institute for Medical Informatics, Biometry and Epidemiology, Medical Faculty, University Duisburg-Essen, Essen, Germany.; School of Public Health, Department of Epidemiology Boston University, Boston, MA, United States of America., Kuklik N; Institute for Medical Informatics, Biometry and Epidemiology, Medical Faculty, University Duisburg-Essen, Essen, Germany., Brinkmann M; Institute for Medical Informatics, Biometry and Epidemiology, Medical Faculty, University Duisburg-Essen, Essen, Germany.; Center for Clinical Trials Essen, University Hospital Essen, Essen, Germany., Maurer GD; Department of Neurology, University Hospital Frankfurt, Goethe University Frankfurt, Germany., Soda H; Klinik für Akutneurologie mit Überregionaler Stroke Unit, Klinischer Neurophysiologie und Intensivmedizin, Rhön-Klinikum Campus Bad Neustadt, Bad Neustadt, Germany., Pohlmann C; Department of Neurology, Asklepios Klinik Barmbek, Hamburg, Germany., Hilker-Roggendorf R; Department of Neurology, Klinikum Vest, Recklinghausen.; Ruhr-University, Bochum, Germany., Popovic N; Department of Neurology, Evangelisches Krankenhaus Hattingen, Hattingen, Germany., Kraft P; Klinikum Main-Spessart Lohr, Germany., Mackert BM; Department of Neurology, Vivantes Auguste-Viktoria Hospital, Berlin, Germany., Eschenfelder CC; Human Pharma Germany, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany., Weimar C; Institute for Medical Informatics, Biometry and Epidemiology, Medical Faculty, University Duisburg-Essen, Essen, Germany.; BDH Clinic Elzach, Elzach, Germany.

المصدر: European stroke journal [Eur Stroke J] 2024 Sep; Vol. 9 (3), pp. 696-703. Date of Electronic Publication: 2024 Apr 03.

نوع المنشور: Journal Article; Observational Study; Multicenter Study; Comparative Study

بيانات الدورية: Publisher: SAGE Publications Ltd Country of Publication: England NLM ID: 101688446 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2396-9881 (Electronic) Linking ISSN: 23969873 NLM ISO Abbreviation: Eur Stroke J Subsets: MEDLINE

مواضيع طبية MeSH: Factor Xa Inhibitors*/adverse effects , Factor Xa Inhibitors*/therapeutic use , Factor Xa Inhibitors*/administration & dosage , Ischemic Stroke*/drug therapy , Ischemic Attack, Transient*/drug therapy , Ischemic Attack, Transient*/mortality , Vitamin K*/antagonists & inhibitors , Hemorrhage*/chemically induced, Humans ; Female ; Male ; Aged ; Prospective Studies ; Middle Aged ; Aged, 80 and over ; Anticoagulants/adverse effects ; Anticoagulants/therapeutic use ; Anticoagulants/administration & dosage ; Registries ; Dabigatran/therapeutic use ; Dabigatran/adverse effects ; Dabigatran/administration & dosage ; Administration, Oral ; Treatment Outcome

المؤلفون: Alikhan R; University Hospital of Wales and Cardiff University School of Medicine, Cardiff, Wales, United Kingdom. Electronic address: Raza.Alikhan@wales.nhs.uk., Nour M; University of California, Los Angeles, California, United States., Yasaka M; Fukuoka Neurosurgical Hospital, Fukuoka, Japan., Ofori-Asenso R; AstraZeneca, Cambridge, United Kingdom., Axelsson-Chéramy S; AstraZeneca, Gothenburg, Sweden., Chen H; AstraZeneca, Wilmington, Delaware, United States., Seghal V; University College London Hospital, London, United Kingdom., Yokobori S; Nippon Medical School, Tokyo, Japan., Koch B; AstraZeneca, Wilmington, Delaware, United States., Tiede A; Hannover Medical School, Hannover, Germany., Cash BD; University of Texas Health Science Center at Houston, Houston, Texas, United States., Maegele M; Cologne-Merheim Medical Center, Cologne, Germany., Singer AJ; Stony Brook University, New York, New York, United States.

المصدر: Thrombosis research [Thromb Res] 2024 Aug; Vol. 240, pp. 109046. Date of Electronic Publication: 2024 Jun 05.

نوع المنشور: Journal Article; Multicenter Study; Observational Study

بيانات الدورية: Publisher: Pergamon Press Country of Publication: United States NLM ID: 0326377 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-2472 (Electronic) Linking ISSN: 00493848 NLM ISO Abbreviation: Thromb Res Subsets: MEDLINE

مواضيع طبية MeSH: Factor Xa Inhibitors*/therapeutic use , Factor Xa Inhibitors*/adverse effects , Hemorrhage*/chemically induced, Humans ; Female ; Male ; Aged ; Middle Aged ; Cohort Studies

المؤلفون: Chang YC; Department of Medicine, Danbury Hospital, Danbury, Connecticut, USA., Song J; Department of Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA., Chi KY; Department of Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA., Gao W; Department of Medicine, Danbury Hospital, Danbury, Connecticut, USA., Chang Y; Section of Neurosurgery, Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Chiang CH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Hsia YP; Department of Family Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan., Chiang CH; Department of Medicine, Mount Auburn Hospital, Harvard Medical School, Cambridge, Massachusetts, USA.

المصدر: British journal of haematology [Br J Haematol] 2024 Aug; Vol. 205 (2), pp. 473-477. Date of Electronic Publication: 2024 Jun 21.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Warfarin*/therapeutic use , Warfarin*/adverse effects , Multiple Myeloma*/drug therapy , Multiple Myeloma*/complications , Multiple Myeloma*/mortality , Factor Xa Inhibitors*/therapeutic use , Factor Xa Inhibitors*/adverse effects , Anticoagulants*/therapeutic use , Anticoagulants*/adverse effects, Humans ; Female ; Male ; Aged ; Middle Aged ; Venous Thrombosis/prevention & control ; Venous Thrombosis/etiology ; Immunomodulating Agents/therapeutic use ; Immunomodulating Agents/adverse effects ; Aged, 80 and over ; Pulmonary Embolism/prevention & control ; Pulmonary Embolism/etiology

المؤلفون: Pessôa RL; Medical School, Universidade do Vale do Taquari, Lajeado, Brazil., Kessler VG; Medical School, Universidade do Vale do Taquari, Lajeado, Brazil., Becker GG; Medical School, Universidade do Vale do Taquari, Lajeado, Brazil., Garcia GM; Medical School, Universidade do Vale do Taquari, Lajeado, Brazil., Duarte Araldi PV; Medical School, Universidade Regional do Noroeste do Estado do Rio Grande do Sul, Ijuí, Brazil., Aver PV; Medical School, Universidade do Contestado, Mafra, Brazil.

المصدر: Vascular and endovascular surgery [Vasc Endovascular Surg] 2024 Aug; Vol. 58 (6), pp. 633-639. Date of Electronic Publication: 2024 May 05.

نوع المنشور: Journal Article; Systematic Review; Meta-Analysis; Review

بيانات الدورية: Publisher: Sage Publications Country of Publication: United States NLM ID: 101136421 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-9116 (Electronic) Linking ISSN: 15385744 NLM ISO Abbreviation: Vasc Endovascular Surg Subsets: MEDLINE

مواضيع طبية MeSH: Venous Thromboembolism*/drug therapy , Venous Thromboembolism*/diagnosis , Venous Thromboembolism*/blood , Network Meta-Analysis* , Randomized Controlled Trials as Topic* , Hemorrhage*/chemically induced , Recurrence* , Factor Xa Inhibitors*/adverse effects , Factor Xa Inhibitors*/administration & dosage, Humans ; Aged ; Administration, Oral ; Risk Factors ; Treatment Outcome ; Age Factors ; Female ; Male ; Aged, 80 and over ; Risk Assessment ; Anticoagulants/adverse effects ; Anticoagulants/administration & dosage ; Acute Disease

المؤلفون: Lenard A; Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, University of Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.; Partner Site Heidelberg, German Center for Infection Research, Heidelberg, Germany., Hermann SA; Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, University of Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.; Partner Site Heidelberg, German Center for Infection Research, Heidelberg, Germany., Stoll F; Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, University of Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.; Partner Site Heidelberg, German Center for Infection Research, Heidelberg, Germany., Burhenne J; Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, University of Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.; Partner Site Heidelberg, German Center for Infection Research, Heidelberg, Germany., Foerster KI; Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, University of Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.; Partner Site Heidelberg, German Center for Infection Research, Heidelberg, Germany., Mikus G; Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, University of Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.; Partner Site Heidelberg, German Center for Infection Research, Heidelberg, Germany., Meid AD; Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, University of Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.; Partner Site Heidelberg, German Center for Infection Research, Heidelberg, Germany., Haefeli WE; Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, University of Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.; Partner Site Heidelberg, German Center for Infection Research, Heidelberg, Germany., Blank A; Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, University of Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany. antje.blank@med.uni-heidelberg.de.; Partner Site Heidelberg, German Center for Infection Research, Heidelberg, Germany. antje.blank@med.uni-heidelberg.de.

المصدر: Cardiovascular drugs and therapy [Cardiovasc Drugs Ther] 2024 Aug; Vol. 38 (4), pp. 747-756. Date of Electronic Publication: 2023 Mar 04.

نوع المنشور: Journal Article; Clinical Trial

بيانات الدورية: Publisher: Kluwer Academic For The International Society For Cardiovascular Pharmacotherapy Country of Publication: United States NLM ID: 8712220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7241 (Electronic) Linking ISSN: 09203206 NLM ISO Abbreviation: Cardiovasc Drugs Ther Subsets: MEDLINE

مواضيع طبية MeSH: Factor Xa Inhibitors*/pharmacokinetics , Factor Xa Inhibitors*/administration & dosage , Drug Interactions* , Clarithromycin*/pharmacokinetics , Clarithromycin*/pharmacology , Clarithromycin*/administration & dosage , Pyridines*/pharmacokinetics , Pyridines*/administration & dosage , Pyridines*/pharmacology , Pyridines*/blood , Thiazoles*/pharmacokinetics , Thiazoles*/administration & dosage , Thiazoles*/pharmacology , Thiazoles*/blood , Cytochrome P-450 CYP3A Inhibitors*/pharmacology , Healthy Volunteers* , Cytochrome P-450 CYP3A*/metabolism , ATP Binding Cassette Transporter, Subfamily B, Member 1*/antagonists & inhibitors , ATP Binding Cassette Transporter, Subfamily B, Member 1*/metabolism, Humans ; Male ; Adult ; Young Adult ; Female ; Rivaroxaban/pharmacokinetics ; Rivaroxaban/administration & dosage ; Area Under Curve ; Pyrazoles/pharmacokinetics ; Pyrazoles/administration & dosage ; Pyrazoles/blood ; Pyrazoles/pharmacology ; Administration, Oral ; Pyridones/pharmacokinetics ; Pyridones/administration & dosage ; Pyridones/blood ; Middle Aged

المؤلفون: Hunter BR; Indiana University School of Medicine, Indianapolis, Indiana, USA (B.R.H., J.M.K.)., Kirschner JM; Indiana University School of Medicine, Indianapolis, Indiana, USA (B.R.H., J.M.K.).

المصدر: Annals of internal medicine [Ann Intern Med] 2024 Sep; Vol. 177 (9), pp. JC101. Date of Electronic Publication: 2024 Sep 03.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1539-3704 (Electronic) Linking ISSN: 00034819 NLM ISO Abbreviation: Ann Intern Med Subsets: MEDLINE

مواضيع طبية MeSH: Factor Xa Inhibitors*/adverse effects , Factor Xa Inhibitors*/therapeutic use , Thrombosis*/chemically induced, Humans ; Cerebral Hemorrhage/chemically induced ; Male ; Recombinant Proteins ; Factor Xa

المؤلفون: Zou P; Daiichi Sankyo Inc., Basking Ridge, New Jersey, USA., Zahir H; Biogen Inc., Cambridge, Massachusetts, USA., Duggal A; Daiichi Sankyo Inc., Basking Ridge, New Jersey, USA., Pandya G; Daiichi Sankyo Inc., Basking Ridge, New Jersey, USA., Jin J; Daiichi Sankyo Inc., Basking Ridge, New Jersey, USA., Leil TA; Daiichi Sankyo Inc., Basking Ridge, New Jersey, USA.

المصدر: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Sep; Vol. 116 (3), pp. 736-746. Date of Electronic Publication: 2024 Feb 18.

نوع المنشور: Journal Article; Clinical Trial, Phase I

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE

مواضيع طبية MeSH: Pyridines*/pharmacokinetics , Pyridines*/adverse effects , Pyridines*/administration & dosage , Pyridines*/blood , Thiazoles*/pharmacokinetics , Thiazoles*/adverse effects , Thiazoles*/administration & dosage , Thiazoles*/blood , Venous Thromboembolism*/drug therapy , Factor Xa Inhibitors*/pharmacokinetics , Factor Xa Inhibitors*/adverse effects , Factor Xa Inhibitors*/administration & dosage, Humans ; Child ; Child, Preschool ; Adolescent ; Infant ; Male ; Female ; Infant, Newborn ; Dose-Response Relationship, Drug ; Age Factors ; Administration, Oral ; Area Under Curve

المؤلفون: Cafaro A; Chromatography and Mass Spectrometry Section, Central Laboratory of Analysis, IRCCS Istituto Giannina Gaslini, Genoa, Italy., Stella M; UOC Servizio di Sperimentazioni Cliniche Pediatriche, Gaslini Trial Centre, IRCCS Istituto Giannina Gaslini, Genoa, Italy.; Pharmacology and Toxicology Unit, Department of Internal Medicine, University of Genoa, Genoa, Italy., Baiardi G; Pharmacology and Toxicology Unit, Department of Internal Medicine, University of Genoa, Genoa, Italy.; Clinical Pharmacology Unit, Ente ospedaliero Ospedali Galliera, Genoa, Italy., Barco S; Chromatography and Mass Spectrometry Section, Central Laboratory of Analysis, IRCCS Istituto Giannina Gaslini, Genoa, Italy., Pigliasco F; Chromatography and Mass Spectrometry Section, Central Laboratory of Analysis, IRCCS Istituto Giannina Gaslini, Genoa, Italy., Bandettini R; Chromatography and Mass Spectrometry Section, Central Laboratory of Analysis, IRCCS Istituto Giannina Gaslini, Genoa, Italy., Nanni L; Laboratory Medicine Unit, Department of Laboratory Diagnostics, IRCCS Policlinico San Martino, Genoa, Italy., Mattioli F; Pharmacology and Toxicology Unit, Department of Internal Medicine, University of Genoa, Genoa, Italy.; Clinical Pharmacology Unit, Ente ospedaliero Ospedali Galliera, Genoa, Italy., Cangemi G; Chromatography and Mass Spectrometry Section, Central Laboratory of Analysis, IRCCS Istituto Giannina Gaslini, Genoa, Italy.

المصدر: Journal of mass spectrometry : JMS [J Mass Spectrom] 2024 Sep; Vol. 59 (9), pp. e5081.

نوع المنشور: Journal Article; Validation Study

بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 9504818 Publication Model: Print Cited Medium: Internet ISSN: 1096-9888 (Electronic) Linking ISSN: 10765174 NLM ISO Abbreviation: J Mass Spectrom Subsets: MEDLINE

مواضيع طبية MeSH: Pyridones*/blood , Tandem Mass Spectrometry*/methods , Pyrazoles*/blood , Pyrazoles*/pharmacokinetics , Drug Monitoring*/methods , Dried Blood Spot Testing*/methods , Factor Xa Inhibitors*/blood , Factor Xa Inhibitors*/pharmacokinetics, Humans ; Reproducibility of Results ; Chromatography, Liquid/methods ; Limit of Detection ; Linear Models

المؤلفون: Chen X; Department of Cardiology, Sanming First Affiliated Hospital of Fujian Medical University, Sanming, Fujian, China., Zhu W; Department of Cardiology, the First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China., Lin M; Department of Cardiology, Sanming First Affiliated Hospital of Fujian Medical University, Sanming, Fujian, China. Electronic address: 13850818587@139.com.

المصدر: European journal of internal medicine [Eur J Intern Med] 2024 Sep; Vol. 127, pp. 154-156. Date of Electronic Publication: 2024 May 19.

نوع المنشور: Letter; Comparative Study

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 9003220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0828 (Electronic) Linking ISSN: 09536205 NLM ISO Abbreviation: Eur J Intern Med Subsets: MEDLINE

مواضيع طبية MeSH: Atrial Fibrillation*/drug therapy , Vitamin K*/antagonists & inhibitors , Renal Dialysis* , Anticoagulants*/therapeutic use , Anticoagulants*/adverse effects , Factor Xa Inhibitors*/therapeutic use , Factor Xa Inhibitors*/adverse effects, Humans ; Aged ; Male ; Female ; Stroke/prevention & control ; Stroke/etiology ; Kidney Failure, Chronic/therapy ; Kidney Failure, Chronic/complications ; Middle Aged ; Hemorrhage/chemically induced ; Warfarin/therapeutic use ; Warfarin/adverse effects

المؤلفون: Favatella N; Bristol Myers Squibb, Princeton, NJ, USA., Dalton D; Bristol Myers Squibb, Princeton, NJ, USA., Byon W; Pfizer, Groton, CT, USA., Merali SJ; Bristol Myers Squibb, Princeton, NJ, USA., Klem C; Bristol Myers Squibb, Princeton, NJ, USA.

المصدر: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2024 Sep; Vol. 13 (9), pp. 961-973. Date of Electronic Publication: 2024 Jul 24.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2160-7648 (Electronic) Linking ISSN: 2160763X NLM ISO Abbreviation: Clin Pharmacol Drug Dev Subsets: MEDLINE

مواضيع طبية MeSH: Drug Interactions* , Factor Xa Inhibitors*/administration & dosage , Factor Xa Inhibitors*/adverse effects , Factor Xa Inhibitors*/pharmacokinetics , Pyrazoles*/administration & dosage , Pyrazoles*/adverse effects , Pyrazoles*/pharmacokinetics , Pyridones*/administration & dosage , Pyridones*/adverse effects , Pyridones*/pharmacokinetics, Humans ; Anticoagulants/administration & dosage ; Anticoagulants/adverse effects ; Anticoagulants/pharmacokinetics ; COVID-19 Drug Treatment/methods ; Neoplasms/drug therapy ; Risk Assessment ; Thromboembolism/drug therapy ; Thromboembolism/etiology ; Clinical Trials, Phase III as Topic